These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26617861)

  • 41. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray.
    Jentzsch T; Robl B; Husmann M; Bode-Lesniewska B; Fuchs B
    Anticancer Res; 2014 Aug; 34(8):3881-9. PubMed ID: 25075009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
    J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High expression of PKM2 as a poor prognosis indicator is associated with radiation resistance in cervical cancer.
    Zhao Y; Shen L; Chen X; Qian Y; Zhou Q; Wang Y; Li K; Liu M; Zhang S; Huang X
    Histol Histopathol; 2015 Nov; 30(11):1313-20. PubMed ID: 25936600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
    Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
    Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.
    Liu ZX; Hong L; Fang SQ; Tan GH; Huang PG; Zeng Z; Xia X; Wang XX
    Tumour Biol; 2016 Nov; 37(11):14923-14928. PubMed ID: 27644251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
    Kim MS; Lee SY; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jung ST; Jeon DG
    J Orthop Sci; 2009 May; 14(3):292-7. PubMed ID: 19499296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis].
    Ozger H; Eralp L; Atalar AC; Toker B; Esberk Ateş L; Sungur M; Bilgiç B; Ayan I
    Acta Orthop Traumatol Turc; 2009; 43(1):28-34. PubMed ID: 19293613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis.
    Zhu H; Cai H; Tang M; Tang J
    Clin Transl Oncol; 2014 Aug; 16(8):732-8. PubMed ID: 24338507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.
    Zhao H; Wu Y; Chen Y; Liu H
    Int J Clin Oncol; 2015 Dec; 20(6):1233-43. PubMed ID: 26077139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma.
    Liu Y; Zhang F; Zhang Z; Wang D; Cui B; Zeng F; Huang L; Zhang Q; Sun Q
    Pathol Res Pract; 2017 Aug; 213(8):895-899. PubMed ID: 28647210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
    Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
    Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcome.
    Salas S; Huynh TK; Giorgi R; Deville JL; Bollini G; Curvale G; Blesius A; Gentet JC; Bui B; Bouvier C; Duffaud F
    Eur J Cancer Care (Engl); 2011 May; 20(3):322-9. PubMed ID: 20148934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C-erbB-2 expression and prognostic significance in osteosarcoma.
    Yalçin B; Gedikoğlu G; Kutluk T; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Blood Cancer; 2008 Aug; 51(2):222-7. PubMed ID: 18421709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.
    Won KY; Park HR; Park YK
    Tumori; 2009; 95(3):311-6. PubMed ID: 19688969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
    Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of bax, cytochrome C, and caspase-8 protein expression in primary osteosarcoma.
    Kaseta MK; Gomatos IP; Khaldi L; Tzagarakis GP; Alevizos L; Themistocleous GS; Leandros E; Soucacos PN
    Hybridoma (Larchmt); 2007 Dec; 26(6):355-62. PubMed ID: 18158779
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.